| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.18 | 0.2 |